Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration
about
The complete genome sequence of the murine respiratory pathogen Mycoplasma pulmonisDiscrimination of bacterial lipoproteins by Toll-like receptor 6Molecular biology and pathogenicity of mycoplasmasInflammation-inducing Factors of Mycoplasma pneumoniaePyrexia, anorexia, adipsia, and depressed motor activity in rats during systemic inflammation induced by the Toll-like receptors-2 and -6 agonists MALP-2 and FSL-1Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6Microbial stimulation by Mycoplasma fermentans synergistically amplifies IL-6 release by human lung fibroblasts in response to residual oil fly ash (ROFA) and nickelLipopeptide vaccines illustrate the potential role of subtype-crossreactive T cells in the control of highly virulent influenzaCytadherence of Mycoplasma pneumoniae induces inflammatory responses through autophagy and toll-like receptor 4.Peptide vaccines and peptide libraries.Molecular cloning and functional characterization of chicken toll-like receptors. A single chicken toll covers multiple molecular patterns.Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinisLipopeptide structure determines TLR2 dependent cell activation level.Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartmentsIncreasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptorsCrosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes: a recipe for impaired wound healingEffects of the TLR2 agonists MALP-2 and Pam3Cys in isolated mouse lungsMycoplasmal lipopeptide MALP-2 induces the chemoattractant proteins macrophage inflammatory protein 1alpha (MIP-1alpha), monocyte chemoattractant protein 1, and MIP-2 and promotes leukocyte infiltration in mice.Mycoplasma fermentans and TNF-beta interact to amplify immune-modulating cytokines in human lung fibroblastsDifferential posttranslational processing confers intraspecies variation of a major surface lipoprotein and a macrophage-activating lipopeptide of Mycoplasma fermentans.Phase variations of the Mycoplasma penetrans main surface lipoprotein increase antigenic diversityLipid extract of Mycoplasma penetrans proteinase K-digested lipid-associated membrane proteins rapidly activates NF-kappaB and activator protein 1.P48 major surface antigen of Mycoplasma agalactiae is homologous to a malp product of Mycoplasma fermentans and belongs to a selected family of bacterial lipoproteinsEffect of MALP-2, a lipopeptide from Mycoplasma fermentans, on bone resorption in vitro.Modulation of cytokine profiles by the Mycoplasma superantigen Mycoplasma arthritidis mitogen parallels susceptibility to arthritis induced by M. arthritidis.Complement activation in Mycoplasma fermentans-induced mycoplasma clearance from infected cells: probing of the organism with monoclonal antibodies against M161Ag.Characterization of a multigene family undergoing high-frequency DNA rearrangements and coding for abundant variable surface proteins in Mycoplasma agalactiae.Isolation and partial purification of macrophage- and dendritic cell-activating components from Mycoplasma arthritidis: association with organism virulence and involvement with Toll-like receptor 2.Site-specific proteolysis of the MALP-404 lipoprotein determines the release of a soluble selective lipoprotein-associated motif-containing fragment and alteration of the surface phenotype of Mycoplasma fermentansIdentification and functional mapping of the Mycoplasma fermentans P29 adhesin.Interaction of mycoplasmas with host cells.Environment-mediated accumulation of diacyl lipoproteins over their triacyl counterparts in Staphylococcus aureusTLR-based immune adjuvants.Interactions between mycoplasma lipid-associated membrane proteins and the host cells.Homologue of macrophage-activating lipoprotein in Mycoplasma gallisepticum is not essential for growth and pathogenicity in tracheal organ culturesToll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice.Differential inhibitory mechanism of cyclic AMP on TNF-alpha and IL-12 synthesis by macrophages exposed to microbial stimuliToll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethalAssessment of Lactobacillus gasseri as a candidate oral vaccine vectorSpiralin, a mycoplasmal membrane lipoprotein, induces T-cell-independent B-cell blastogenesis and secretion of proinflammatory cytokines
P2860
Q22065997-F399609F-9231-4B07-9739-113C8C4DCAB3Q24291383-023EA3F1-DE67-44CF-ACFC-0B33CA9B4365Q24548575-647A9233-9565-4027-BA72-E549BDD292AEQ26749594-5DFE6B76-08D0-493B-A209-B597B676C5DDQ28579018-90E709D9-28CD-4F79-B34D-3647D141BBB4Q28646148-5AED2438-408D-4BE4-814B-1FE4A6568E94Q28652362-BBB43737-D399-425B-B722-21CC973F134DQ30379213-4C944417-C059-4D95-B0C7-2E6EE973B3EFQ30583680-97033C99-6085-48ED-B071-86F4F0043BB5Q30992372-8B2882DF-7FD6-4063-A8AF-FBDA33E4B219Q31014753-CA90D755-E762-4FE4-92BF-EDD2AD197B25Q32018362-77A6940A-4633-4342-9BF3-B420A927A741Q33228861-D1C5E3AD-1438-4E75-B88D-064AEB4E718EQ33565626-AD6AECB3-9AF0-435E-B203-45BF442DAC03Q33591916-05DC6F97-C0C4-41A5-9816-4E7F849764D1Q33690017-AC068834-F34F-4424-8734-629CB578D1C1Q33761304-ED756403-CFEE-40EC-9CE6-CD9053F17267Q33876738-4D9F56B5-0763-45B0-9DF3-BBBBFE79A0CBQ33964529-43A4A1AA-BBD8-479B-A1EB-FE3D25F80510Q34000316-694BCD06-0BB9-4628-BFC1-F27CD8884673Q34000776-E38DD768-D45E-4372-A772-D69B012546D8Q34001138-6EFF9BFA-3B24-4962-A318-B87593A17A2AQ34002632-CCA10ADC-771B-45E5-B4BB-39F63878E230Q34002676-20F883FE-9AC0-4170-A704-1DF96D345C5CQ34003483-E697345B-1DE9-4607-BDFE-496DC69047CAQ34003700-8AF675B4-4696-4D3E-9374-6CA3DF9AC55AQ34007669-13A270FD-F077-4C0C-B261-CF13A2FB975CQ34033844-764E3690-3A99-46A8-951E-BA9DC19A1CDAQ34120333-7F58CD54-385F-4C89-B31C-CD454D6DD32FQ34130915-309C3731-94FC-440C-810E-EBE5D4BCD956Q34186781-F125BFA1-A6DD-4D57-8D75-182777451E5AQ34216615-AD814EF7-B288-47D6-BFE6-FE2DDF6AED17Q34400322-57E6830B-32CE-4C8D-9648-AEA0E6AC2498Q34619536-E428B4F8-8180-47C6-B049-87CEAFA6EE1BQ34891388-EF2E55B4-607C-4F43-820D-04684066161CQ35005601-C016EF6F-999E-44A3-A188-0684192BCEF3Q35029066-E200CA14-3A95-4799-9A36-4857E718AE4CQ35164987-497E37A7-B261-4F13-AF40-AE45DCB20AAEQ35530209-AD300AF2-B1D8-4055-947B-D8805990DE10Q35557029-FC81DF2D-158B-4A30-8848-3AD379509425
P2860
Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Isolation, structure elucidati ...... ing at picomolar concentration
@en
type
label
Isolation, structure elucidati ...... ing at picomolar concentration
@en
prefLabel
Isolation, structure elucidati ...... ing at picomolar concentration
@en
P2093
P2860
P356
P1476
Isolation, structure elucidati ...... ing at picomolar concentration
@en
P2093
P2860
P304
P356
10.1084/JEM.185.11.1951
P407
P577
1997-06-01T00:00:00Z